Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. - Tanni KA; Truong CB; Almahasis S; Qian J (BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2021)